The Institute of Cancer Research (ICR), London carried out the study, which says that genetic inheritance is much more important in testicular cancer than in other cancer types,
Insulin glargine 300 units/mL is a concentrated formulation of the glargine molecule identified in Lantus (insulin glargine 100 units/mL). It forms a compact subcutaneous depot with a reduced
MT-1303, which targets the sphingosine 1-phosphate (S1P) receptor, completed a successful Phase II clinical trial in multiple sclerosis (MS). Biogen is assessing a rapid development program in the
The companies will commence pre-clinical animal studies in Duchenne Muscular Dystrophy (DMD). The collaboration aims to expand existing preclinical proof of concept data in additional DMD animal models.
Under a five-year deal, the parties will apply clinical trial bioinformatics to find cancer treatments for individual patients. AstraZeneca has agreed to provide £11.5m to support clinical bioinformatics
Under the research collaboration, scientists at both the companies will evaluate potential novel mechanisms as targeted anti-fibrotics in multi-organ fibrosis. Evotec will deliver its drug discovery platform whereas
LobSor is developing Lecigon, a treatment for advanced Parkinson’s disease currently at clinical stage. Recipharm will manufacture the drug in its initial three years on the market. The
Amdipharm was established from the merger of Amdipharm and the Mercury Pharma Group in 2013. Cinven bought both firms in 2012 and later merged them. The deal will
The research collaboration will be undertaken at MIT in Boston, US and Novo’s research facilities in Måløv and Hillerød, Denmark. It intends to develop the next generation of
The office said it did not improve the efficacy of the current approved drug. Indian Patent Office assistant controller of patents and designs Bharat N.S said in an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.